Gene · 3108
Papers2,126
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,126
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues. | Nat Commun | 2023 | 37012232 | PubTator, text mining | PubMed |
| Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis. | Front Endocrinol (Lausanne) | 2023 | 37008925 | PubTator, text mining | PubMed |
| Comprehensive analysis of immunogenic cell death associated genes expression, tumor microenvironment, and prognosis in hepatocellular carcinoma. | Front Pharmacol | 2023 | 36998605 | PubTator, text mining | PubMed |
| A multiscale mechanistic model of human dendritic cells for in-silico investigation of immune responses and novel therapeutics discovery. | Front Immunol | 2023 | 36993954 | PubTator, text mining | PubMed |
| Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers. | Curr Oncol | 2023 | 36975409 | PubTator, text mining | PubMed |
| Loading dynamics of one SARS-CoV-2-derived peptide into MHC-II revealed by kinetic models. | Biophys J | 2023 | 36964657 | PubTator, text mining | PubMed |
| Re-generation of cytotoxic γδT cells with distinctive signatures from human γδT-derived iPSCs. | Stem Cell Reports | 2023 | 36963392 | PubTator, text mining | PubMed |
| Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment. | Front Pharmacol | 2023 | 36959853 | PubTator, text mining | PubMed |
| Immune gene patterns and characterization of the tumor immune microenvironment associated with cancer immunotherapy efficacy. | Heliyon | 2023 | 36950600 | PubTator, text mining | PubMed |
| Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis. | Front Oncol | 2023 | 36950551 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. | Front Immunol | 2023 | 36949947 | PubTator, text mining | PubMed |
| An in silico approach to the identification of diagnostic and prognostic markers in low-grade gliomas. | PeerJ | 2023 | 36945359 | PubTator, text mining | PubMed |
| Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma. | Front Immunol | 2023 | 36936912 | PubTator, text mining | PubMed |
| Toward a general model of CD4+ T cell subset specification and memory cell formation. | Immunity | 2023 | 36921574 | PubTator, text mining | PubMed |
| SMN post-translational modifications in spinal muscular atrophy. | Front Cell Neurosci | 2023 | 36874214 | PubTator, text mining | PubMed |
| Prognostic implication of cuproptosis related genes associates with immunity in Ewing's sarcoma. | Transl Oncol | 2023 | 36871208 | PubTator, text mining | PubMed |
| HLA-DMB alleles and haplotypes in Ecuador (Cuenca) Amerindians: Importance for HLA and disease studies. | Hum Immunol | 2023 | 36870854 | PubTator, text mining | PubMed |
| An mRNA mix redirects dendritic cells towards an antiviral program, inducing anticancer cytotoxic stem cell and central memory CD8+ T cells. | Front Immunol | 2023 | 36860873 | PubTator, text mining | PubMed |
| A clustering linear combination method for multiple phenotype association studies based on GWAS summary statistics. | Sci Rep | 2023 | 36854754 | PubTator, text mining | PubMed |
| Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets. | Kidney Blood Press Res | 2023 | 36854280 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3108/papers?page=12